title: Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
abstract: It is recommended that routine bone scans not be adopted for follow-up of patients with stage I-II breast cancer. Bone scintigraphy should be reserved for evaluation of patients presenting with symptoms suggestive of bone metastases.
authors.affiliation: Department of Radiology and Medicine, University of Cincinnati Hospital, OH 45267-0577, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Wikenheiser
authors.forename: E B
authors.initials: EB
authors.lastname: Silberstein
mesh_terms: D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D018579:Patient Selection; D011788:Quality of Life; D011877:Radionuclide Imaging / Q000191:economics; D015996:Survival Rate